Population dynamics of immunological synapse formation induced by bispecific T cell engagers predict clinical pharmacodynamics and treatment resistance
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Population dynamics of immunological synapse formation induced by bispecific T cell engagers predict clinical pharmacodynamics and treatment resistance
Authors
Keywords
-
Journal
eLife
Volume 12, Issue -, Pages -
Publisher
eLife Sciences Publications, Ltd
Online
2023-07-25
DOI
10.7554/elife.83659
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis
- (2022) Franco Locatelli et al. Blood Advances
- Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells
- (2021) Wei Xiong et al. MOLECULAR THERAPY
- Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma
- (2021) Mehmet Kemal Samur et al. Nature Communications
- Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release
- (2021) Kevin Dang et al. Journal for ImmunoTherapy of Cancer
- Understanding the Spatial Topology of Artificial Immunological Synapses Assembled in T Cell-Redirecting Strategies: A Major Issue in Cancer Immunotherapy
- (2020) Pedro Roda-Navarro et al. Frontiers in Cell and Developmental Biology
- Development of a minimal physiologically-based pharmacokinetic/pharmacodynamic model to characterize target cell depletion and cytokine release for T cell-redirecting bispecific agents in humans
- (2020) Xiling Jiang et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
- (2020) Kristen Fousek et al. LEUKEMIA
- Mechanistic Prediction of First-in-Human Dose for Bispecific CD3/EpCAM T-cell engager Antibody M701, using an Integrated PK/PD Modeling Method
- (2020) Ling Song et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Predicting tumor killing and T-cell activation by T-Cell Bispecific antibodies as a function of target expression: combining in vitro experiments with systems modeling
- (2020) Arthur J Van De Vyver et al. MOLECULAR CANCER THERAPEUTICS
- A Translational Quantitative Systems Pharmacology Model for CD3 Bispecific Molecules: Application to Quantify T Cell-Mediated Tumor Cell Killing by P-Cadherin LP DART®
- (2019) Alison Betts et al. AAPS Journal
- Modulation of Target Antigen Density Improves CAR T Cell Functionality and Persistence
- (2019) Sneha Ramakrishna et al. CLINICAL CANCER RESEARCH
- Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
- (2019) Xinjie Xu et al. Frontiers in Immunology
- Microfluidics to Mimic Blood Flow in Health and Disease
- (2018) Bernhard Sebastian et al. Annual Review of Fluid Mechanics
- Bispecific antibody based therapeutics: Strengths and challenges
- (2018) Archana Thakur et al. BLOOD REVIEWS
- Bispecific antibodies in haematological malignancies
- (2018) Andreas Viardot et al. CANCER TREATMENT REVIEWS
- Development of a Target cell-Biologics-Effector cell (TBE) complex-based cell killing model to characterize target cell depletion by T cell redirecting bispecific agents
- (2018) Xiling Jiang et al. mAbs
- The immunological synapse as a pharmacological target
- (2018) Francesca Finetti et al. PHARMACOLOGICAL RESEARCH
- Heterogeneity of surface CD19 and CD22 expression in B lymphoblastic leukemia
- (2018) Jaclyn Rosenthal et al. AMERICAN JOURNAL OF HEMATOLOGY
- Dynamic metrics-based biomarkers to predict responders to anti-PD-1 immunotherapy
- (2018) Can Liu et al. BRITISH JOURNAL OF CANCER
- Blinatumomab Pharmacodynamics and Exposure-Response Relationships in Relapsed/Refractory Acute Lymphoblastic Leukemia
- (2017) Min Zhu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
- (2017) E. Mejstríková et al. Blood Cancer Journal
- A unifying mathematical framework for experimental TCR-pMHC kinetic constants
- (2017) Jose Faro et al. Scientific Reports
- Resistance to anti-CD19/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking
- (2016) Friederike Braig et al. BLOOD
- Blinatumomab, a Bispecific T-cell Engager (BiTE®) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications
- (2016) Min Zhu et al. CLINICAL PHARMACOKINETICS
- Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment
- (2015) G. Zugmaier et al. BLOOD
- Blinatumomab: enlisting serial killer T-cells in the war against hematologic malignancies
- (2015) Britny Rogala et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
- (2015) Max S Topp et al. LANCET ONCOLOGY
- Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia
- (2014) Max S. Topp et al. JOURNAL OF CLINICAL ONCOLOGY
- A Comprehensive Mathematical Model for Three-Body Binding Equilibria
- (2013) Eugene F. Douglass et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
- (2012) W. Haso et al. BLOOD
- How many dendritic cells are required to initiate a T-cell response?
- (2012) S. Celli et al. BLOOD
- Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab
- (2012) M. Klinger et al. BLOOD
- Methods of solving rapid binding target-mediated drug disposition model for two drugs competing for the same receptor
- (2012) Xiaoyu Yan et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Blinatumomab: A historical perspective
- (2012) Dirk Nagorsen et al. PHARMACOLOGY & THERAPEUTICS
- Interspecies Scaling in Pharmacokinetics: A Novel Whole-Body Physiologically Based Modeling Framework to Discover Drug Biodistribution Mechanisms in vivo
- (2011) Cierra Hall et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A Mathematical Framework for Analyzing T Cell Receptor Scanning of Peptides
- (2010) Andreas Jansson BIOPHYSICAL JOURNAL
- The kinetics of two-dimensional TCR and pMHC interactions determine T-cell responsiveness
- (2010) Jun Huang et al. NATURE
- Differential Cellular Internalization of Anti-CD19 and -CD22 Immunotoxins Results in Different Cytotoxic Activity
- (2008) X. Du et al. CANCER RESEARCH
- Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody
- (2008) R. Bargou et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now